Different drug-eluting stents (DES) may have different performance in bifurcation PCI. Thus, we compared the performance of a novel zotarolimus-eluting stent (ZRS) with that obtained using two other DES in bifurcation PCI.
Burzotta, F., Trani, C., Talarico, G. P., Tommasino, A., Todaro, D., Coluccia, V., Pirozzolo, G., Niccoli, G., Leone, A. M., Porto, I., Schiavoni, G., Crea, F., Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents, <<CARDIOVASCULAR REVASCULARIZATION MEDICINE>>, 2013; 14 (3): 122-127. [doi:10.1016/j.carrev.2013.01.002] [http://hdl.handle.net/10807/53511]
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents
Burzotta, Francesco;Trani, Carlo;Talarico, Giovanni Paolo;Tommasino, Antonella;Todaro, Daniel;Coluccia, Valentina;Niccoli, Giampaolo;Leone, Antonio Maria;Porto, Italo;Schiavoni, Giovanni;Crea, Filippo
2013
Abstract
Different drug-eluting stents (DES) may have different performance in bifurcation PCI. Thus, we compared the performance of a novel zotarolimus-eluting stent (ZRS) with that obtained using two other DES in bifurcation PCI.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
